U.S. FDA Seeks Regional Office In India To Inspect Exports To U.S.
This article was originally published in PharmAsia News
The U.S. FDA, which has been helping India establish a similar agency, wants to establish regional offices in India to better monitor safety and quality issues involved with Indian-made pharmaceuticals and food products. India has the most manufacturing plants for drugs sold in the United States and accounts for about half of U.S. FDA approvals for generic drugs. Michael Leavitt, secretary of the U.S. Health and Human Services Department, said the U.S. also was open to India's government having people located in the U.S. and other places where the FDA works. He said basing U.S. personnel abroad is part of a general strategy to maintain American standards in products the U.S. imports. (Click here for more
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.